Patents by Inventor Michael Sereda

Michael Sereda has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11614089
    Abstract: A positive displacement device that converts energy, namely positive displacement compressors that rotate in a single rotational direction to displace working fluid contained in operating chambers. The device described herein is particularity advantageous for the ability to achieve high compression ratios in combination with high discharge pressure and high volumetric throughput in a single stage.
    Type: Grant
    Filed: April 13, 2021
    Date of Patent: March 28, 2023
    Inventors: Alejandro Juan, Michael Sereda-Mohr, Erik Farrell
  • Patent number: 11168683
    Abstract: A pressure balancing system for a pump. In one example, the pressure balancing system has: a housing; a first rotor a first shaft, a first face surface; a second rotor, a second face surface adjacent the first face surface of the first rotor; the face of the first rotor, the face of the second rotor, and an inner surface of the housing forming at least one working fluid chamber; an annular ring fitted around a shaft, adjacent a first pressure chamber having a fluid connection through the housing; the annular ring configured to bias the first rotor toward the second rotor when fluid is supplied under pressure to the first pressure chamber; a fluid conduit is configured to convey fluid to a pressure chamber between the housing and the annular ring to bias the annular ring thus biasing the first rotor toward the second rotor.
    Type: Grant
    Filed: March 12, 2020
    Date of Patent: November 9, 2021
    Assignee: Exponential Technologies, Inc.
    Inventors: Kristjan Gottfried, Erik Farrell, Michael Sereda-Mohr
  • Publication number: 20210301825
    Abstract: A positive displacement device that converts energy, namely positive displacement compressors that rotate in a single rotational direction to displace working fluid contained in operating chambers. The device described herein is particularity advantageous for the ability to achieve high compression ratios in combination with high discharge pressure and high volumetric throughput in a single stage.
    Type: Application
    Filed: April 13, 2021
    Publication date: September 30, 2021
    Inventors: Alejandro Juan, Michael Sereda-Mohr, Erik Farrell
  • Publication number: 20210260053
    Abstract: The present invention provides methods for treating, preventing, or delaying the onset of Charcot-Marie-Tooth Disease type 1A (CMT1A), by administering to a subject in need thereof a combination comprising baclofen, sorbitol and naltrexone, or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: March 8, 2021
    Publication date: August 26, 2021
    Inventors: Daniel Cohen, Ilya Chumakov, Rodolphe Hajj, Aude Milet, Serguei Nabirochkin, Klaus-Armin Nave, Thomas Prukop, Michael Sereda
  • Patent number: 10975869
    Abstract: A positive displacement device that converts energy, namely positive displacement compressors that rotate in a single rotational direction to displace working fluid contained in operating chambers. The device described herein is particularity advantageous for the ability to achieve high compression ratios in combination with high discharge pressure and high volumetric throughput in a single stage.
    Type: Grant
    Filed: December 13, 2018
    Date of Patent: April 13, 2021
    Assignee: Exponential Technologies, Inc.
    Inventors: Alejandro Juan, Michael Sereda-Mohr, Erik Farrell
  • Patent number: 10940147
    Abstract: The present invention provides methods for treating, preventing, or delaying the onset of Charcot-Marie-Tooth Disease type 1A (CMT1A), by administering to a subject in need thereof a combination comprising baclofen, sorbitol and naltrexone, or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: July 8, 2019
    Date of Patent: March 9, 2021
    Assignee: Pharnext
    Inventors: Daniel Cohen, Ilya Chumakov, Rodolphe Hajj, Aude Milet, Serguei Nabirochkin, Klaus-Armin Nave, Thomas Prukop, Michael Sereda
  • Publication number: 20200030314
    Abstract: The present invention provides methods for treating, preventing, or delaying the onset of Charcot-Marie-Tooth Disease type 1A (CMT1A), by administering to a subject in need thereof a combination comprising baclofen, sorbitol and naltrexone, or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: July 8, 2019
    Publication date: January 30, 2020
    Inventors: Daniel Cohen, Ilya Chumakov, Rodolphe Hajj, Aude Milet, Serguei Nabirochkin, Klaus-Armin Nave, Thomas Prukop, Michael Sereda
  • Publication number: 20190271317
    Abstract: A positive displacement device that converts energy, namely positive displacement compressors that rotate in a single rotational direction to displace working fluid contained in operating chambers. The device described herein is particularity advantageous for the ability to achieve high compression ratios in combination with high discharge pressure and high volumetric throughput in a single stage.
    Type: Application
    Filed: December 13, 2018
    Publication date: September 5, 2019
    Inventors: Alejandro Juan, Michael Sereda-Mohr, Erik Farrell
  • Patent number: 10383870
    Abstract: The present invention provides methods for treating, preventing, or delaying the onset of Charcot-Marie-Tooth Disease type 1A (CMT1A), by administering to a subject in need thereof a combination comprising baclofen, sorbitol and naltrexone, or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: June 9, 2017
    Date of Patent: August 20, 2019
    Assignee: PHARNEXT
    Inventors: Daniel Cohen, Ilya Chumakov, Rodolphe Hajj, Aude Milet, Serguei Nabirochkin, Klaus-Armin Nave, Thomas Prukop, Michael Sereda
  • Publication number: 20180000813
    Abstract: The present invention provides methods for treating, preventing, or delaying the onset of Charcot-Marie-Tooth Disease type 1A (CMT1A), by administering to a subject in need thereof a combination comprising baclofen, sorbitol and naltrexone, or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: June 9, 2017
    Publication date: January 4, 2018
    Inventors: Daniel Cohen, Ilya Chumakov, Rodolphe Hajj, Aude Milet, Serguei Nabirochkin, Klaus-Armin Nave, Thomas Prukop, Michael Sereda